Figure 3.

The predictive ability of miRNAs as a biomarker for cancer stage across cancer types

(A) Three signature miRNAs and their contributions to stage prediction across eight cancer types. Each miRNA contributed to at least four cancers. The size of the line is proportional to the percent contribution toward the stage prediction.

(B) Fourteen miRNAs contributed across cancers, and each miRNA contributed to at least three cancers.

(C) Fifty miRNAs contributed to at least two cancers.

(D) Heatmap showing 67 miRNAs and their ranks based on their predictive ability across 15 cancer types.